LightPath™ Imaging System: Lightpoint Medical
Our client asked:
Our client, Lightpoint Medical, needed a technology and product development partner to help it develop the world’s first molecular imaging system, designed to detect cancerous tissue in real time during surgery. The initial focus of the project was on breast cancer surgery where up to 40% of patients are faced with additional surgery. As well as reducing the need for reoperation, the goal was to help reduce the likelihood of recurrence, patient anxiety and the enormous cost to health services.
The project story:
- Identified detector technologies for both Positrons and Cerenkov Luminscence – equivalent to seeing a 3mW LED at 15km
- Modelled the relative performance of approaches
- Performed early Proof-of-Principle demonstration and collaborated with medical research teams
- Proposed commercially viable solutions for the operating theatre and pathology lab
- Undertook full product development of LightPath™ to manufacturing prototypes for clinical studies
Results: deliverables and outcomes
- The world’s first intra-operative molecular imaging system to help surgeons ensure they have removed all cancerous tissue in a single operation
- The technology has the potential for imaging of numerous cancer types
- The LightPath™ system obtained CE Mark approval in 2015 and was launched in Europe that year
The product won ‘new product of the year’ award at the 2016 BEEAs
Medical markets
Discover our breadth of expertise across the MedTech market and how we collaborate to drive the advancement of medical technology.
Medical services
Find out how our specialist MedTech Ru0026D consulting services can help you transform patient outcomes through innovative medical device development.
Contact us
We’d be delighted to discuss your challenges and explore how innovative thinking could help solve them. If you’d like us to get in touch, please complete the contact us form.